Insider Stock Trading History of Lowrance David L


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Lowrance David L since year 2005. The trader's CIK number is 1408498. At the time of this reporting, Lowrance David L is the Chief Financial Officer of Adventrx Pharmaceuticals Inc . (stock ticker symbol ANX). See this page for all insider trading activities at Adventrx Pharmaceuticals Inc .

Note that in the past Lowrance David L also reported insider trading activities as an insider of the following companies:
Stock purchases, sales, and option exercises reported by insider Lowrance David L since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2017-06-07 SVRA Adventrx Pharmaceuticals Inc Buy 2,100 4.75 9,975
2014-08-18 M?????? Acucela Inc. Sale 40,500 7.05 285,525
2014-08-18 M?????? Acucela Inc. Option Ex 40,500 4.52 183,059

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Lowrance David L (Chief Financial Officer of Adventrx Pharmaceuticals Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.